Denis Migliorini

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Mesenchymal Stem Cells

Top Venues

Cancer research communications

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Stephen J Bagley, Zev A Binder, Lamia Lamrani, Eliana Marinari, Arati S Desai, Mac Lean P Nasrallah, Eileen Maloney, Steven Brem, Robert A Lustig, Goldie Kurtz, Michelle Alonso-Basanta, Pierre-Emmanuel Bonte, Christel Goudot, Wilfrid Richer, Eliane Piaggio, Shawn Kothari, Lea Guyonnet, Coralie L Guerin, Joshua J Waterfall, Suyash Mohan, Wei-Ting Hwang, Oliver Y Tang, Meghan Logun, Meghna Bhattacharyya, Kelly Markowitz, Devora Delman, Amy Marshall, E John Wherry, Sebastian Amigorena, Gregory L Beatty, Jennifer L Brogdon, Elizabeth Hexner, Denis Migliorini, Cécile Alanio, Donald M O'Rourke
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial. Nature cancer 5 (3) (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Darel Martínez, Eliana Marinari, Suzel Davanture, Luis Castillo Cantero, Sarah Erraiss, Millicent Dockerill, Sofia Barluenga, Nicolas Winssinger, Karl Schaller, Philippe Bijlenga, Shahan Momjian, Christel Voize, Stéphanie R Tissot, Lana Elias Kandalaft, Philippe Hammel, Pierre Cosson, Paul R Walker, Valérie Dutoit, Denis Migliorini
PTPRZ1-targeting RNA CAR T cells exert antigen-specific and bystander antitumor activity in glioblastoma. Cancer immunology research (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Stephen J Bagley, Zev A Binder, Lamia Lamrani, Eliana Marinari, Arati S Desai, Mac Lean P Nasrallah, Eileen Maloney, Steven Brem, Robert A Lustig, Goldie Kurtz, Michelle Alonso-Basanta, Pierre-Emmanuel Bonte, Christel Goudot, Wilfrid Richer, Eliane Piaggio, Shawn Kothari, Lea Guyonnet, Coralie L Guerin, Joshua J Waterfall, Suyash Mohan, Wei-Ting Hwang, Oliver Y Tang, Meghan Logun, Meghna Bhattacharyya, Kelly Markowitz, Devora Delman, Amy Marshall, E John Wherry, Sebastian Amigorena, Gregory L Beatty, Jennifer L Brogdon, Elizabeth Hexner, Denis Migliorini, Cécile Alanio, Donald M O'Rourke
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial. Nature cancer 5 (3) (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer research communications 4 (8) (2024)
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, Virginie Ancrenaz, Emily Charrier, Marie-Claude Belkouch, Olivier Von Rohr, Muriel Urwyler, Claudio deVito, Jessica Renaux, Jean Villard, Olivier Rubin, Julien Grogg, Nicolas Mach
A first-in-human phase I clinical study with MVX-ONCO-1, a personalized active immunotherapy, in patients with advanced solid tumors. Cancer research communications (2024)
Stephen J Bagley, Zev A Binder, Lamia Lamrani, Eliana Marinari, Arati S Desai, Mac Lean P Nasrallah, Eileen Maloney, Steven Brem, Robert A Lustig, Goldie Kurtz, Michelle Alonso-Basanta, Pierre-Emmanuel Bonte, Christel Goudot, Wilfrid Richer, Eliane Piaggio, Shawn Kothari, Lea Guyonnet, Coralie L Guerin, Joshua J Waterfall, Suyash Mohan, Wei-Ting Hwang, Oliver Y Tang, Meghan Logun, Meghna Bhattacharyya, Kelly Markowitz, Devora Delman, Amy Marshall, E John Wherry, Sebastian Amigorena, Gregory L Beatty, Jennifer L Brogdon, Elizabeth Hexner, Denis Migliorini, Cécile Alanio, Donald M O'Rourke
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial. Nature cancer (2024)
Ali Ghasemi, Amaia Martinez-Usatorre, Luqing Li, Mehdi Hicham, Alan Guichard, Rachel Marcone, Nadine Zangger, Bruno Torchia, Darel Martínez, Suzel Davanture, Mirian Fernández-Vaquero, Chaofan Fan, Jakob Janzen, Yahya Mohammadzadeh, Raphael Genolet, Nahal Mansouri, Mathias Wenes, Denis Migliorini, Mathias F Heikenwälder, Michele De Palma
Cytokine-armed dendritic cell progenitors for antigen-agnostic cancer immunotherapy. Nature cancer (2023)
Zoe Johnson, Chiara Tarantelli, Elisa Civanelli, Luciano Cascione, Filippo Spriano, Amy Fraser, Pritom Shah, Tyzoon Nomanbhoy, Sara Napoli, Andrea Rinaldi, Karolina Niewola-Staszkowska, Michael Lahn, Dominique Perrin, Mathias Wenes, Denis Migliorini, Francesco Bertoni, Lars van der Veen, Giusy Di Conza
IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance. Cancer research communications 3 (4) (2023)